Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.01.24 | Sonic Foundry Announces Fourth Quarter and Fiscal Year 2023 Results | 369 | Business Wire | MADISON, Wis.--(BUSINESS WIRE)--Sonic Foundry, Inc. (OTC: SOFO), the trusted leader in developing comprehensive video recording and streaming solutions for corporations, health organizations and... ► Artikel lesen | |
04.01.24 | Franklin Covey Reports Strong Financial Results to Start Fiscal 2024 | 367 | Business Wire | SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement that creates, and on a subscription basis, distributes world-class content, training... ► Artikel lesen | |
04.01.24 | .Everest Group, Ltd.: Everest Group to Hold Fourth Quarter 2023 Earnings Conference Call on Thursday, February 8, 2024 | 365 | Business Wire | Everest Group, Ltd. ("Everest") (NYSE: EG) will hold its fourth quarter 2023 earnings conference call on Thursday, February 8, 2024, beginning at 8:00 am Eastern Time.
Dial in details can be obtained... ► Artikel lesen | |
04.01.24 | Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer | 397 | Business Wire | Collaborative clinical study will investigate a novel combination of Debio 0123, Debiopharm's potent, brain penetrant inhibitor of WEE1, and lunresertib, Repare Therapeutics' first-in-class PKMYT1... ► Artikel lesen | |
04.01.24 | Repare Therapeutics Inc.: Repare Therapeutics and Debiopharm Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer | 448 | Business Wire | Collaborative clinical study will investigate a novel combination of lunresertib, Repare's first-in-class PKMYT1 inhibitor, and Debio 0123, Debiopharm's potent, brain-penetrant inhibitor of WEE1
Repare... ► Artikel lesen | |
04.01.24 | Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer | 469 | Business Wire | Novocure (NASDAQ: NVCR) today announced the appointment of Nicolas Leupin, M.D., Ph.D., MBA to the role of Chief Medical Officer. Dr. Leupin brings a proven track record of leadership and accomplishment... ► Artikel lesen | |
04.01.24 | Kopin Corporation and MICLEDI Microdisplays Announce Agreement to Collaborate on microLED Displays for Next Generation Vision Solutions | 1.201 | Business Wire | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high performance micro-displays for defense, enterprise, consumer and medical products, and MICLEDI... ► Artikel lesen | |
04.01.24 | Sourcefit sichert sich eine strategische Investition von 9 Basil, NextGen Ventures und Rocket Equities | 361 | Business Wire | Finanzierungsrunde stärkt Partnerschaften, Expansion und Entwicklung von KI-gesteuerter Arbeitsplatztechnologie Sourcefit, ein führender internationaler Anbieter von Business Processing Outsourcing... ► Artikel lesen | |
04.01.24 | Omega Funds gibt Beförderung von Francesco Draetta zum Managing Director bekannt | 307 | Business Wire | Omega Funds, ein führendes internationales Investmentunternehmen, das sich auf die Bereitstellung wirkungsvoller Medikamente für Patienten konzentriert, gibt hocherfreut die Beförderung von Francesco... ► Artikel lesen | |
04.01.24 | Adani Portfolio: Indiens Oberster Gerichtshof weist Klage gegen die Adani-Gruppe in der Hindenburg-Affäre ab | 325 | Business Wire | Die Berufung des Antragstellers auf den OCCRP-Bericht, wonach die indische Marktaufsichtsbehörde bei ihrer Untersuchung nachlässig war, wird zurückgewiesen Weist die indische Kapitalmarktaufsichtsbehörde... ► Artikel lesen | |
04.01.24 | Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 4 January 2024 | 345 | Business Wire | Regulatory News:
Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) ("PSH") today announced that it has purchased, through PSH's agent, Jefferies International Limited ("Jefferies"), the... ► Artikel lesen | |
04.01.24 | IMPLANET: Launch of an issue of new shares with preferential subscription rights | 802 | Business Wire | Fundraising of €6.38 million with preferential subscription rights, through the issue of New Shares with a ratio of 19 New Shares for 8 preferential subscription rights (which may be increased... ► Artikel lesen | |
04.01.24 | AM Best Affirms Credit Ratings of Life Insurance Corporation (International) B.S.C. (c) | 372 | Business Wire | AM Best has affirmed the Financial Strength Rating of B (Fair) and the Long-Term Issuer Credit Rating of "bb" (Fair) of Life Insurance Corporation (International) B.S.C. (c) (LICI) (Bahrain). The... ► Artikel lesen | |
04.01.24 | Maurel & Prom: 2024 Financial Calendar | 491 | Business Wire | Regulatory News:
Etablissements Maurel Prom (Euronext Paris: MAU, ISIN FR0000051070) announces its financial communication calendar for 2024.
25 January 2024: Activity in 2023
Press... ► Artikel lesen | |
04.01.24 | Hyundai Mobis wählt Wind River Studio, um die Entwicklung softwaredefinierter Fahrzeuge zu beschleunigen | 320 | Business Wire | Wind River, ein weltweiter Marktführer bei Software für unternehmenskritische intelligente Systeme, gab heute bekannt, dass Hyundai Mobis, einer der weltweit größten Innovatoren und Zulieferer von... ► Artikel lesen | |
04.01.24 | Trillora Packaging Solutions: Ein neues Kapitel der Verpackungsoptimierung und Leistung | 273 | Business Wire | Übernahme von Billerud Managed Packaging durch die Mimir Group im September: Nutzung von Verpackungsexpertise und asiatischem Produktionsnetzwerk, Umbenennung in Trillora Packaging Solutions.
Trillora... ► Artikel lesen | |
04.01.24 | Gecina: Monthly Disclosure of the Total Number of Shares and Voting Rights | 403 | Business Wire | (In conformity with the article 223-16 of the general regulation of AMF (Autorité des Marchés Financiers)
Regulatory News:
Gecina (Paris:GFC):
Date Total number of shares... ► Artikel lesen | |
04.01.24 | ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital | 495 | Business Wire | Article L233-8-II of the French Commercial Code
Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX):
Market:... ► Artikel lesen | |
04.01.24 | Groupe Berkem: Half-year Report on the Liquidity Contract With TP ICAP (Europe) SA | 450 | Business Wire | Regulatory News:
Under the liquidity contract agreement between GROUPE BERKEM (Paris:ALKEM) and TP ICAP (Europe) SA, on December 29, 2023, the following resources were included in the liquidity... ► Artikel lesen | |
04.01.24 | Groupe Berkem: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital | 448 | Business Wire | Regulatory News:
Groupe Berkem (Paris:ALKEM):
Date Number of shares
outstanding Total gross voting
rights (1) Total net voting
rights(2)
December 31... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 3.792 |
NVIDIA | 3.186 |
RHEINMETALL | 2.040 |
RENK GROUP | 1.773 |
THYSSENKRUPP | 1.674 |
STEYR MOTORS | 1.615 |
BYD | 1.571 |
BAYER | 1.561 |
NEL | 1.450 |
DEUTZ | 1.439 |
TUI | 1.397 |
VOLKSWAGEN | 1.228 |
EVOTEC | 1.146 |
NOVO NORDISK | 1.128 |
MERCEDES-BENZ | 1.008 |
XIAOMI | 943 |
AMAZON | 926 |
PUMA | 886 |
PORSCHE AG | 869 |
BASF | 858 |
COMMERZBANK | 785 |
DEUTSCHE BANK | 783 |
NORDEX | 771 |
AIXTRON SE | 728 |
VONOVIA | 637 |